Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors

por Scholtes, Rosalie A., van Baar, Michaël J. B., Kok, Megan D., Bjornstad, Petter, Cherney, David Z. I., Joles, Jaap A., van Raalte, Daniël H.
Publicado 2021

Mechanisms underlying the blood pressure lowering effects of dapagliflozin, exenatide, and their combination in people with type 2 diabetes: a secondary analysis of a randomized tr...

por van Ruiten, Charlotte C., Smits, Mark M., Kok, Megan D., Serné, Erik H., van Raalte, Daniël H., Kramer, Mark H. H., Nieuwdorp, Max, IJzerman, Richard G.
Publicado 2022